Hindustan Foods Ltd Q4 FY26 Earnings Analysis

Published 3 Jul 2026 | Market Cap: ₹7.0K Cr

Price

587

Market Cap

₹7.0K Cr

P/E Ratio

43.2

Revenue Rank

Rank 2

Margin Rank

Rank 3

Earnings Summary

The management has given a clear mandate to grow each business unit (BU) at 20%, aiming for overall company growth at 20%. Management targets 20% growth in each business unit (BU), aiming for overall company growth of 20% annually through FY30.

📊 Revenue & Sales Performance

Rank 2
  • The management has given a clear mandate to grow each business unit (BU) at 20%, aiming for overall company growth at 20%.
  • Growth targets are seen as achievable despite macroeconomic challenges due to the company's small share in large market segments.
  • By FY2030, assuming consumption rebounds and inflation eases, growth should be easier with possible tailwinds.
  • Volume production, e.g., at the Panipat ice cream facility, is expected to increase significantly (over 50% volume growth between FY26 and FY27).
  • Transition to a conversion cost model (net revenue) in some segments may reduce reported sales but not actual volume or profitability.
  • Footwear division expects INR700-800 crores turnover in FY27, growing beyond last year’s targets despite raw material cost pressures.
  • The company remains bullish on growth in home care, beverages, ice cream, and healthcare export segments.

📈 Profitability & Margins

Rank 3
  • Management targets 20% growth in each business unit (BU), aiming for overall company growth of 20% annually through FY30. (Page 23)
  • Confident to achieve PAT of INR 200-220 crores for FY27, indicating 40-50% growth in PAT compared to FY26. (Pages 22 and 12)
  • EBITDA margins of around 9-10% are achievable, especially if customers agree to a conversion cost model, which could drive PAT margins to 10%. (Page 23)
  • Operational leverage and better utilization of newly commissioned assets expected to drive profitable growth, although some segments face short-term headwinds (e.g., footwear). (Pages 6, 14, 15)
  • Shared manufacturing expected to deliver higher ROCE and profitability than dedicated manufacturing, supporting margin expansion. (Pages 16, 15)
  • Broad diversification across five verticals helps mitigate risk and supports balanced growth across segments. (Page 14)

🏗️ Capital Expenditure Plans

Yes
  • INR150 crores of new contracts signed since April (last 45 days), with more announcements expected within the year (Page 19).
  • Total gross block target of approximately INR2,150 crores by FY27 (Page 17, 18, 20).
  • Capex split expected to remain around 60% dedicated manufacturing and 40% shared facilities (Page 17, 20).
  • Brownfield expansion in ice cream facilities at Lucknow and Panipat (Page 8).
  • Focus on multiple new units across the country, especially in beverages, aiming to become the largest independent bottler by FY27 (Page 17).
  • Capital invested includes large projects such as the Panipat facility (INR200 crores invested) which started production in April FY26, and acquisitions like Aurangabad and cone facility (Page 12).
  • Working capital financing and cash buffers are adequate to support these incremental investments despite working capital challenges (Page 20).

💰 Fundraising & Capital Structure

No
  • The company currently has a net debt to equity ratio of about 0.84x, with some cash on the balance sheet, providing sufficient buffer for planned investments.
  • Working capital financing is well managed, with efforts to secure working capital credit across product lines, ensuring no constraint on capex investment.
  • Discussions on incremental capex financing indicate reliance on internal accruals and available debt capacity, with no immediate mention of new equity fundraising.
  • The company is aware of working capital and GST duty inversion challenges but appears confident in managing financing without additional equity issuance.
  • No explicit announcement or plan for new fundraising through debt or equity was mentioned; focus remains on prudent balance sheet management and funding capex through existing resources and credit lines.

📋 Order Book & Pipeline

Yes
  • INR 150 crores of new contracts have been signed since April (last 45 days), but this is not the full-year guidance.
  • The company has a strong project pipeline with ongoing discussions with several customers.
  • Additional new contract announcements are expected before the end of the year to satisfy shareholders and the Board of Directors.
  • The footwear division has an order book visibility for the end of the year, with expected turnover of INR 700-800 crores in FY27.
  • Overall, strong engagement and project pipeline across verticals, especially in home care, beverages, and ice cream segments.
  • Management confident about sustaining profitable growth backed by execution momentum across business verticals.

Key Metrics

Revenue

Rank 2

Margin

Rank 3

Capex

Yes

Fundraise

No

Order Book

Yes

Frequently Asked Questions

What were Hindustan Foods Ltd Q4 FY26 results?

The management has given a clear mandate to grow each business unit (BU) at 20%, aiming for overall company growth at 20%. Management targets 20% growth in each business unit (BU), aiming for overall company growth of 20% annually through FY30.

What is Hindustan Foods Ltd share price analysis?

Hindustan Foods Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 43.2 with a market cap of ₹6,990 Cr. Investors should review the full earnings analysis for detailed insights.

Is Hindustan Foods Ltd planning capital expenditure?

INR150 crores of new contracts signed since April (last 45 days), with more announcements expected within the year (Page 19).

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Hindustan Foods's management said in earlier quarters

Others in Diversified FMCG this season

  • Hind. Unilever (Q4 FY26)

    1,200 crores ARR), Personal Care premium products, Home Care liquids, and Lifestyle Nutrition (Pages 7, 8, 10, 15). Hind. Unilever Q4 FY26 results — Market…